The Article: Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Nijssen, Estelle C et al. The Lancet, Volume 389, Issue 10076
Contrast-induced nephropathy (CIN) has historically been considered the 3rd most common cause of acute kidney injury (AKI) in patients admitted to the hospital. It is thought to increase in-hospital morbidity and mortality, although it usually resolves and leaves ...